# Denosumab

## Prolia inj 60mg

| TAH Drug Code      | [**IPRO6**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IPRO6)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of postmenopausal women w/ osteoporosis at high risk for fracture; bone loss in women receiving adjuvant aromatase inhibitor therapy for breast cancer; bone loss in men receiving androgen deprivation therapy for prostate cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | SC, 60 mg every 6 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypocalcemia. Pregnancy & lactation. Severe renal impairment. Hypersensitivity to any component of the product; facial swelling and urticaria have been reported.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Facial swelling and urticaria have been reported. Influenza, hypocalcemia, headache, lethargy, dyspnea, diarrhea, nausea, dyspepsia, bone pain, arthralgia, myalgia, flu-like symptoms, pyrexia, rigors, fatigue, pain, asthenia. Local site reactions. Osteonecrosis of the jaw. Cardiovascular: Peripheral edema (Paget's Disease, 3%; osteoporosis, 4.6% to 5.5%; bone metastasis, 21% ) Endocrine metabolic: Weight decreased (bone metastasis, 16% ) Gastrointestinal: Abdominal pain (osteoporosis (female), 0.9% to 4.6%; osteoporosis (male), 7.9%; Paget's disease, 2%; hypercalcemia of malignancy, 16%; bone metastasis, 14% ), Constipation (Paget's disease, 6%; hypercalcemia of malignancy, 27%; bone metastasis, 31% ), Diarrhea (osteoporosis, 5.2% to 6%; Paget's disease, 6%; hypercalcemia of malignancy, 17%; bone metastasis, 24% ), Loss of appetite (osteoporosis, 1% to 2%; Paget's disease, 2%; hypercalcemia of malignancy, 9%; bone metastasis, 22% ), Nausea (osteoporosis, 4.5% to 8.5%; Paget's disease, 9%; hypercalcemia of malignancy, 29%; bone metastasis, 46% ), Vomiting (Paget's disease, 2%; osteoporosis, 3.4% to 4.6%; hypercalcemia of malignancy, 14%; bone metastasis, 32% ) Musculoskeletal: Arthralgia (osteoporosis (female), 17.9% to 23.8%; osteoporosis (male), 11.1%; hypercalcemia of malignancy, 5% to less than 10%; Paget's disease, 9%; bone metastasis, 21% ), Backache (Paget's disease, 4%; bone metastasis, 15% ) Neurologic: Asthenia (osteoporosis, 3.2 to 5.3%; Paget's disease, 2%; bone metastasis, 24% ), Dizziness (osteoporosis, 2% to 7.6%; Paget's disease, 9%; bone metastasis, 18% ), Headache (osteoporosis (female), 3.9% to 12.4%; osteoporosis (male), 15%; Paget's disease, 11%; hypercalcemia of malignancy, 5% to less than 10%; bone metastasis, 19% ), Insomnia (hypercalcemia of malignancy, 15%; bone metastasis, 16% ), Paresthesia (Paget's disease, 2%; bone metastasis, 15% .) Renal: Nephrotoxicity (bone metastasis, 11% to 17% ) Other: Fatigue (osteoporosis (female), 2.1% to 5.4%; osteoporosis (male), 17.6%; Paget's disease, 8%; bone metastasis, 39% ), Fever (osteoporosis (female), 7% to 18%; osteoporosis (male), 15.7%; Paget's disease, 3% to 11%; hypercalcemia of malignancy, 44%; bone metastasis, 32% ) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## Xgeva inj 120mg

| TAH Drug Code      | [**IXGE**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IXGE)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bone metastases from solid tumors: Prevention of skeletal-related events (eg, fracture, spinal cord compression, bone pain requiring surgery/radiation therapy) in patients with bone metastases from solid tumors. Giant cell tumor of bone: Treatment of giant cell tumor of bone (in adults and skeletally mature adolescents) that is unresectable or where surgical resection is likely to result in severe morbidity. Hypercalcemia of malignancy: Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy.                                                                                                                                                                                                        |
| Dosing             | SC, bone metastasis associated with solid tumors 120 mg every 4 weeks. Giant cell tumor of bone, hypercalcemia of malignancy 120 mg every 4 weeks, with additional 120 mg doses on days 8 and 15 of first month of therapy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity. Severe, symptomatic hypocalcaemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | >10%: Cardiovascular: Hypertension (11%) Central nervous system: Fatigue (Xgeva: <45%), headache (Xgeva: 13% to 24%), peripheral edema (5%; Xgeva: 24%) Dermatologic: Dermatitis (4% to 11%), eczema (4% to 11%), skin rash (3% to 11%) Endocrine & metabolic: Hypophosphatemia (Xgeva: 32%), hypocalcemia (2%; Xgeva: 3% to 18%) Gastrointestinal: Nausea (Xgeva: 31%), decreased appetite (Xgeva: 24%), vomiting (Xgeva: 24%), constipation (Xgeva: 21%), diarrhea (Xgeva: 20%) Hematologic & oncologic: Anemia (Xgeva: 21%) Infection: Influenza (11%) Neuromuscular & skeletal: Weakness (Xgeva: ?45%), arthralgia (7% to 14%), limb pain (10% to 12%), back pain (8% to 12%) Respiratory: Dyspnea (Xgeva: 21% to 27%), cough (Xgeva: 15%) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

